- Home
- BHVN vs MLTX Comparison
BHVN vs MLTX Comparison
Compare BHVN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- MLTX
- Stock Information
- Founded
- BHVN 2013
- MLTX 2021
- Country
- BHVN United States
- MLTX Switzerland
- Employees
- BHVN N/A
- MLTX N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- BHVN Health Care
- MLTX Health Care
- Exchange
- BHVN Nasdaq
- MLTX Nasdaq
- Market Cap
- BHVN 3.6B
- MLTX 3.4B
- IPO Year
- BHVN 2017
- MLTX N/A
- Fundamental
- Price
- BHVN $36.17
- MLTX $52.17
- Analyst Decision
- BHVN Strong Buy
- MLTX Strong Buy
- Analyst Count
- BHVN 13
- MLTX 9
- Target Price
- BHVN $63.00
- MLTX $77.43
- AVG Volume (30 Days)
- BHVN 1.1M
- MLTX 190.2K
- Earning Date
- BHVN 11-12-2024
- MLTX 11-07-2024
- Dividend Yield
- BHVN N/A
- MLTX N/A
- EPS Growth
- BHVN N/A
- MLTX N/A
- EPS
- BHVN N/A
- MLTX N/A
- Revenue
- BHVN N/A
- MLTX N/A
- Revenue This Year
- BHVN N/A
- MLTX N/A
- Revenue Next Year
- BHVN $197.10
- MLTX N/A
- P/E Ratio
- BHVN N/A
- MLTX N/A
- Revenue Growth
- BHVN N/A
- MLTX N/A
- 52 Week Low
- BHVN $26.80
- MLTX $37.55
- 52 Week High
- BHVN $62.21
- MLTX $64.98
- Technical
- Relative Strength Index (RSI)
- BHVN 33.02
- MLTX 49.27
- Support Level
- BHVN $36.70
- MLTX $50.60
- Resistance Level
- BHVN $42.13
- MLTX $58.26
- Average True Range (ATR)
- BHVN 2.84
- MLTX 3.00
- MACD
- BHVN -0.67
- MLTX -0.29
- Stochastic Oscillator
- BHVN 13.18
- MLTX 24.35
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.